SU
Supernus Pharmaceuticals, Inc.
SUPN · NASDAQ
$41.38 +0.17% (+$0.07)
1M -15.60%
Market Cap $2.40B
P/E Ratio -
Div. Yield -
ROE 10.42%
Bulios Fair Price
$37.9
8.4% downside
Trenutna cena
$41.38
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SUPN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
31 /100
Expensive P/FCF 127.84x
P/S 2.89x
P/B 2.33x
Growth
25 /100
Declining Book val. growth 6.21%
Rev. growth 2.52%
FCF growth 26.62%
Profitability
26 /100
Weak Op. margin 13.46%
Gross margin 88.07%
FCF margin 2.26%
Quality
7 /100
Poor ROA 7.69%
ROIC 9.12%
Asset turnover 0.58x
Debt
69 /100
Low Int. coverage -50.79x
Debt/Equity 0.04x
Current ratio 2.08x
Stability
50 /100
Moderate EPS volatility 3,229.95%
Beta 0.56x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SUPN
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jack A. Khattar
Employees
778
Headquarters
Rockville
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report